BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 4412373)

  • 1. Cervical-vaginal adenosis after in utero exposure to synthetic estrogens.
    Sherman AI; Goldrath M; Berlin A; Vakhariya V; Banooni F; Michaels W; Goodman P; Brown S
    Obstet Gynecol; 1974 Oct; 44(4):531-45. PubMed ID: 4412373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal and cervical abnormalities, including clear-cell adenocarcinoma, related to prenatal exposure to stilbestrol.
    Scully RE; Robboy SJ; Herbst AL
    Ann Clin Lab Sci; 1974; 4(4):222-33. PubMed ID: 4460850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones.
    Int Surg; 1977 Mar; 62(3):152-5. PubMed ID: 852937
    [No Abstract]   [Full Text] [Related]  

  • 4. Congenital diethylstilbestrol-associated vaginal/cervical adenosis (DES babies).
    Barclay DL
    J Ark Med Soc; 1979 May; 75(12):451-2. PubMed ID: 156173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of DES-associated clear-cell carcinoma: the importance of regular screening.
    Anderson B; Watring WG; Edinger DD; Small EC; Netland AT; Safaii H
    Obstet Gynecol; 1979 Mar; 53(3):293-9. PubMed ID: 424100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of adenosis and clear-cell adenocarcinoma of the genital tract in young females.
    Herbst AL; Scully RE; Robboy SJ
    J Reprod Med; 1975 Jul; 15(1):5-11. PubMed ID: 1151941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symposium on Adolescent Gynecology and Endocrinology. Part II: Secondary amenorrhea, hirsutism in adolescents and the clinical consequences of stilbestrol exposure in utero. The clinical consequences of stilbestrol exposure in utero.
    Kurman RJ
    West J Med; 1979 Dec; 131(6):526-32. PubMed ID: 545869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of the adolescent girl exposed in utero to DES.
    Gerbie MV
    Pediatr Ann; 1981 Dec; 10(12):23-6. PubMed ID: 7335401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The stilbestrol child.
    Franklin EW; Dudley AG; Caputo TA
    J Med Assoc Ga; 1974 Feb; 63(2):66-7. PubMed ID: 4130464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clear cell carcinoma of the cervix and vagina in young women. A report of six cases with association of maternal stilbestrol therapy and adenosis of the vagina.
    Hill EC
    Trans Pac Coast Obstet Gynecol Soc; 1972; 40():15-29. PubMed ID: 4668177
    [No Abstract]   [Full Text] [Related]  

  • 11. Colposcopic and pathologic features in two cases of DES-related vaginal clear-cell adenocarcinoma.
    Blythe JG; Michael H; Hodel KA
    J Reprod Med; 1983 Feb; 28(2):137-46. PubMed ID: 6834354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrauterine diethylstilbestrol exposure and its consequences: pathologic characteristics of vaginal adenosis, clear cell adenocarcinoma, and related lesions.
    Robboy SJ; Scully RE; Welch WR; Herbst AL
    Arch Pathol Lab Med; 1977 Jan; 101(1):1-5. PubMed ID: 576195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of vaginal adenosis in women exposed to diethylstilbestrol in utero.
    Ng AB; Reagan JW; Nadji M; Greening S
    J Reprod Med; 1977 Jan; 18(1):1-13. PubMed ID: 833795
    [No Abstract]   [Full Text] [Related]  

  • 14. Vaginal adenosis, dysplasia, and clear cell adenocarcinoma after diethylstilbestrol treatment in pregnancy.
    Barber HR; Sommers SC
    Obstet Gynecol; 1974 May; 43(5):645-52. PubMed ID: 4822648
    [No Abstract]   [Full Text] [Related]  

  • 15. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
    Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal epithelial changes in young women enrolled in the National Cooperative Diethylstilbestrol Adenosis (DESAD) project.
    O'Brien PC; Noller KL; Robboy SJ; Barnes AB; Kaufman RH; Tilley BC; Townsend DE
    Obstet Gynecol; 1979 Mar; 53(3):300-8. PubMed ID: 424101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical diagnosis of vaginal adenosis.
    Stafl A; Mattingly RF; Foley DV; Fetherston WC
    Obstet Gynecol; 1974 Jan; 43(1):118-28. PubMed ID: 4808952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clear cell carcinoma of the cervix and vagina in young women. A report of six cases with association of maternal stilbestrol therapy and adenosis of the vagina.
    Hill EC
    Am J Obstet Gynecol; 1973 Jun; 116(4):470-84. PubMed ID: 4709483
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaginal and cervical abnormalities after exposure to stilbestrol in utero.
    Herbst AL; Kurman RJ; Scully RE
    Obstet Gynecol; 1972 Sep; 40(3):287-98. PubMed ID: 5054957
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaginal adenosis and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol.
    Newbold RR; McLachlan JA
    Cancer Res; 1982 May; 42(5):2003-11. PubMed ID: 7066910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.